PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway

Although preclinical work with rapalogs suggests potential in the treatment of gastric cancer, they have been less successful clinically. In this study, we report the impact of the investigational drug PP242, a potent and selective small-molecule active-site TORC1/2 kinase inhibitor, on tumor growth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anticancer Drugs
Main Authors: Xing, Xiaofang, Zhang, Lianhai, Wen, Xianzi, Wang, Xiaohong, Cheng, Xiaojing, Du, Hong, Hu, Ying, Li, Lin, Dong, Bin, Li, Ziyu, Ji, Jiafu
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
Preclinical Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222793/
https://ncbi.nlm.nih.gov/pubmed/25035961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000148
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados